243 related articles for article (PubMed ID: 33879449)
1. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Mandigo AC; Yuan W; Xu K; Gallagher P; Pang A; Guan YF; Shafi AA; Thangavel C; Sheehan B; Bogdan D; Paschalis A; McCann JJ; Laufer TS; Gordon N; Vasilevskaya IA; Dylgjeri E; Chand SN; Schiewer MJ; Domingo-Domenech J; Den RB; Holst J; McCue PA; de Bono JS; McNair C; Knudsen KE
Cancer Discov; 2021 Sep; 11(9):2334-2353. PubMed ID: 33879449
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of RB status on E2F1 reprogramming in human cancer.
McNair C; Xu K; Mandigo AC; Benelli M; Leiby B; Rodrigues D; Lindberg J; Gronberg H; Crespo M; De Laere B; Dirix L; Visakorpi T; Li F; Feng FY; de Bono J; Demichelis F; Rubin MA; Brown M; Knudsen KE
J Clin Invest; 2018 Jan; 128(1):341-358. PubMed ID: 29202480
[TBL] [Abstract][Full Text] [Related]
4. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.
Madan E; Gogna R; Kuppusamy P; Bhatt M; Pati U; Mahdi AA
Br J Cancer; 2012 Jul; 107(3):516-26. PubMed ID: 22782351
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway.
Liu F; Zhang Q; Liang Y
J Cell Biochem; 2020 Mar; 121(3):2294-2302. PubMed ID: 31674056
[TBL] [Abstract][Full Text] [Related]
6. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
7. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression.
Benavente CA; Finkelstein D; Johnson DA; Marine JC; Ashery-Padan R; Dyer MA
Oncotarget; 2014 Oct; 5(20):9594-608. PubMed ID: 25338120
[TBL] [Abstract][Full Text] [Related]
8. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
9. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.
Zhou Z; Jiang H; Xia J; Zhang J
Int J Oncol; 2020 Sep; 57(3):697-706. PubMed ID: 32582992
[TBL] [Abstract][Full Text] [Related]
11. The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through the ATM-E2F1 signaling pathway.
Yang Y; Peng XW
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355646
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
13. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation.
Sangwan M; McCurdy SR; Livne-Bar I; Ahmad M; Wrana JL; Chen D; Bremner R
Oncogene; 2012 Nov; 31(48):5019-28. PubMed ID: 22286767
[TBL] [Abstract][Full Text] [Related]
14. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
[TBL] [Abstract][Full Text] [Related]
15. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.
Sharma A; Yeow WS; Ertel A; Coleman I; Clegg N; Thangavel C; Morrissey C; Zhang X; Comstock CE; Witkiewicz AK; Gomella L; Knudsen ES; Nelson PS; Knudsen KE
J Clin Invest; 2010 Dec; 120(12):4478-92. PubMed ID: 21099110
[TBL] [Abstract][Full Text] [Related]
16. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
17. E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma.
Chen M; Zhao Z; Wu L; Huang J; Yu P; Qian J; Ni T; Zhao C
Cell Death Dis; 2022 Sep; 13(9):784. PubMed ID: 36096885
[TBL] [Abstract][Full Text] [Related]
18. Interaction among Rb/p16, Rb/E2F1 and HDAC1 proteins in gallbladder carcinoma.
Wang X; Huang K; Xu L
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):729-31. PubMed ID: 20037816
[TBL] [Abstract][Full Text] [Related]
19. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1.
Rogoff HA; Kowalik TF
Cell Cycle; 2004 Jul; 3(7):845-6. PubMed ID: 15190206
[TBL] [Abstract][Full Text] [Related]
20. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein.
Li CG; Nyman JE; Braithwaite AW; Eccles MR
Oncogene; 2011 Dec; 30(48):4824-34. PubMed ID: 21602887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
